Continuous infusion of interleukin‐2 in children with refractory malignancies

Keyphrases

• Continuous Infusion 100%
• Refractory Malignancy 100%
• Hypotension 66%
• Interleukin-2 66%
• Thrombocytopenia 33%
• Dose Escalation 33%
• Anemia 33%
• Fever 33%
• Vomiting 33%
• Hyponatremia 33%
• Nausea 33%
• Respiratory Distress 33%
• Severe Toxicity 33%
• Immunomodulation 33%
• Weight Gain 33%
• Soluble interleukin-2 Receptor (sIL-2R) 33%
• Serum Interleukins 33%
• 2-cycles 33%
• Hypoalbuminemia 33%
• Recombinant interleukin-2 33%
• Fatality 33%
• Oliguria 33%
• Fluid Bolus 33%
• Objective Tumor Response 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Hypotension 100%
• Interleukin 2 100%
• Neoplasm 50%
• Anemia 50%
• Hyponatremia 50%
• Thrombocytopenia 50%
• Nausea 50%
• Fatality 50%
• Immunomodulation 50%
• Respiratory Distress 50%
• Recombinant Interleukin 2 50%
• Interleukin 2 Receptor 50%
• Oliguria 50%
• Hypoalbuminemia 50%
• Side Effect 50%